MWNA
AHCO icon

Marshall Wace North America’s AdaptHealth AHCO Stock Holding History

Marshall Wace North America’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$15.2M Buy
+653,598
New +$15.8M 0.06% 281
2021
Q1 		– Sell
-533,833
Closed -$20.1M – 1472
2020
Q4 		$20.1M Buy
+533,833
New +$16.5M 0.09% 256

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Marshall Wace North America's AHCO Position: Q3 2021 in Review

Marshall Wace North America opened a new position in AdaptHealth (AHCO) in Q3 2021: 653,598 shares worth $15.2M. The stake represents 0.06% of the portfolio and ranks #281 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in AHCO as recently as Q4 2020.

Marshall Wace North America first reported a position in AHCO in Q4 2020 and has held it in 2 quarters since. The position peaked at $20.1M in Q4 2020. 142 funds tracked by Wall St. Rank hold AHCO as of Q3 2021.

  • Marshall Wace North America held 653,598 shares of AdaptHealth worth $15.2M as of Q3 2021.
  • AdaptHealth was a new Marshall Wace North America position in Q3 2021.
  • AdaptHealth made up 0.06% of Marshall Wace North America's portfolio in Q3 2021, its #281 holding.
  • Marshall Wace North America first reported a position in AdaptHealth in Q4 2020 and has held it in 2 quarters since.
  • Marshall Wace North America's AdaptHealth position peaked at $20.1M in Q4 2020.
  • 142 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.